Concepedia

Eva Aguilera

EA

25

Publications

4.1K

Citations

18

H-Index

1999

Active since

Affiliations

Hospital Universitari Germans Trias i Pujol(Current)

Universitat Autònoma de Barcelona

Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Eva Aguilera is an author at Hospital Universitari Germans Trias i Pujol specializing in medicine, diabetes, and metabolic syndrome.

ORCID

Top concepts

Publications per year

1999–2024

25

Publications

25

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry

Silvia Rodríguez-Fernández, Irma Pujol‐Autonell, Ferran Briansó et al. · Frontiers in Immunology · 2018 · 74 citations · Full text

, , +24

Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System

Dorothee Deiss, Agnieszka Szadkowska, Debbie Gordon et al. · Diabetes Technology & Therapeutics · 2019 · 51 citations · Full text

A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting

Pilar Isabel Beato-Víbora, Ana Chico, Jesús Moreno-Fernández et al. · Diabetes Care · 2023 · 47 citations · Full text

Rows per page

1–5 of 25